{ "@context": "https://schema.org", "@graph": [ { "@type": "BreadcrumbList", "@id": "https://bluejaytx.com/#breadcrumblist", "itemListElement": [ { "@type": "ListItem", "@id": "https://bluejaytx.com#listItem", "position": 1, "name": "Home" } ] }, { "@type": "Organization", "@id": "https://bluejaytx.com/#organization", "name": "Bluejay Therapeutics", "description": "Creating a new paradigm for viral and liver diseases.", "url": "https://bluejaytx.com/", "logo": { "@type": "ImageObject", "url": "https://bluejaytx.com/wp-content/uploads/2023/01/BluejayTx_Logo.png", "@id": "https://bluejaytx.com/#organizationLogo", "width": 400, "height": 400 }, "image": { "@id": "https://bluejaytx.com/#organizationLogo" }, "sameAs": [ "https://www.linkedin.com/company/bluejay-therapeutics/" ] }, { "@type": "WebPage", "@id": "https://bluejaytx.com/#webpage", "url": "https://bluejaytx.com/", "name": "Bluejay Therapeutics", "description": "January 26, 2026Mirum Pharmaceuticals Completes Acquisition of Bluejay TherapeuticsFor the latest information on brelovitug and to follow Mirum's work in chronic hepatitis delta virus and rare diseases, visit https://mirumpharma.com -", "inLanguage": "en-US", "isPartOf": { "@id": "https://bluejaytx.com/#website" }, "breadcrumb": { "@id": "https://bluejaytx.com/#breadcrumblist" }, "datePublished": "2026-01-26T05:06:56-08:00", "dateModified": "2026-01-26T05:33:27-08:00" }, { "@type": "WebSite", "@id": "https://bluejaytx.com/#website", "url": "https://bluejaytx.com/", "name": "Bluejay Therapeutics", "description": "Creating a new paradigm for viral and liver diseases.", "inLanguage": "en-US", "publisher": { "@id": "https://bluejaytx.com/#organization" } } ] }